DE69332702T2 - Verwendung der gensequenz eines promotors zur behandlung rheumatischer erkrankungen - Google Patents

Verwendung der gensequenz eines promotors zur behandlung rheumatischer erkrankungen

Info

Publication number
DE69332702T2
DE69332702T2 DE69332702T DE69332702T DE69332702T2 DE 69332702 T2 DE69332702 T2 DE 69332702T2 DE 69332702 T DE69332702 T DE 69332702T DE 69332702 T DE69332702 T DE 69332702T DE 69332702 T2 DE69332702 T2 DE 69332702T2
Authority
DE
Germany
Prior art keywords
promotor
gene sequence
rheumatic diseases
treating rheumatic
tgagtca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69332702T
Other languages
English (en)
Other versions
DE69332702D1 (de
Inventor
Shunichi Shiozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69332702D1 publication Critical patent/DE69332702D1/de
Publication of DE69332702T2 publication Critical patent/DE69332702T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
DE69332702T 1993-10-29 1993-10-29 Verwendung der gensequenz eines promotors zur behandlung rheumatischer erkrankungen Expired - Lifetime DE69332702T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1993/001581 WO1995011684A1 (fr) 1993-10-29 1993-10-29 Inhibiteur antagoniste de la croissance des cellules mesenchymateuses

Publications (2)

Publication Number Publication Date
DE69332702D1 DE69332702D1 (de) 2003-03-27
DE69332702T2 true DE69332702T2 (de) 2003-10-16

Family

ID=14070618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332702T Expired - Lifetime DE69332702T2 (de) 1993-10-29 1993-10-29 Verwendung der gensequenz eines promotors zur behandlung rheumatischer erkrankungen

Country Status (10)

Country Link
EP (1) EP0733370B1 (de)
KR (1) KR100306376B1 (de)
AT (1) ATE232731T1 (de)
AU (1) AU683626B2 (de)
CA (1) CA2175368C (de)
DE (1) DE69332702T2 (de)
DK (1) DK0733370T3 (de)
ES (1) ES2188597T3 (de)
PT (1) PT733370E (de)
WO (1) WO1995011684A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1340505A3 (de) * 1993-10-29 2004-07-14 The Brigham And Women's Hospital, Inc. Therapeutische Verwendung von cis-Element-Fallen in vivo
US7615538B2 (en) * 1993-10-29 2009-11-10 Shunichi Shiozawa Method for therapy of rheumatoid arthritis
CA2300328A1 (en) 1999-09-14 2001-03-14 Cardiogene Gentherap. Systeme Ag Modulating transcription of genes in vascular cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
WO1991011535A1 (en) * 1990-01-30 1991-08-08 Childrens Hospital Of Los Angeles Inhibition of transcription by double-stranded oligonucleotides
JPH06502532A (ja) * 1990-10-10 1994-03-24 ラ　ジョラ　キャンサー　リサーチ　ファウンデーション 核受容体を用いた転写抑制の方法
US5683985A (en) * 1991-04-18 1997-11-04 The Salk Institute For Biological Studies Oligonucleotide decoys and methods relating thereto
WO1993014768A1 (en) * 1992-01-27 1993-08-05 The Trustees Of The University Of Pennsylvania Methods and compositions for neutralizing intracellular nucleic acid-binding protein biological activity in a cell, including methods and compositions useful to regulate gene function

Also Published As

Publication number Publication date
AU683626B2 (en) 1997-11-20
ATE232731T1 (de) 2003-03-15
DK0733370T3 (da) 2003-04-07
KR960705576A (ko) 1996-11-08
WO1995011684A1 (fr) 1995-05-04
KR100306376B1 (ko) 2001-11-30
DE69332702D1 (de) 2003-03-27
PT733370E (pt) 2003-07-31
EP0733370A1 (de) 1996-09-25
EP0733370A4 (de) 1999-12-29
CA2175368C (en) 2004-07-20
AU5345294A (en) 1995-05-22
CA2175368A1 (en) 1995-05-04
ES2188597T3 (es) 2003-07-01
EP0733370B1 (de) 2003-02-19

Similar Documents

Publication Publication Date Title
IL72643A (en) Gene encoding an analog of human interleukin-ii which substantially retains the biological activity of natural human interleukin-ii,microorganism expression vector containing the gene,microorganisms transformed by the vector and the human interleukin-ii analog produced by the microorganisms
DE3888642T2 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
DE69434209D1 (de) REGULATION DER GENEXPRESSION VON bcl-2
DE3582689D1 (de) Instrumente zum chirurgischen ersetzen von ligamenten.
DE69401230T2 (de) Verwendung von Polyurethanen, die funktionelle Carboxylatogruppe enthalt, zur Haarfestigung
BR9206026A (pt) Análogo de oligonucleotídio, processo para modular a produção ou atividade de uma proteína em um organismo, e, processo para proteger um análogo de oligonucleotídio ou nucleosídio bifuncional
ATE402698T1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
DE68919140D1 (de) Hühner-beta-Actin-Genpromoter enthaltender Vektor zur Expression eines erwünschten Gens.
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE68923903D1 (de) Tomaten.
DE69328025T2 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
DE69332702T2 (de) Verwendung der gensequenz eines promotors zur behandlung rheumatischer erkrankungen
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE69535263D1 (de) Angiotensin ii zur verbesserung der befruchtung
DE68917642D1 (de) Verfahren zur kontinuierlichen Züchtung von haftenden tierischen Zellen.
DE3778158D1 (de) Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants.
PT86581A (de) Verwendung von bakterienlysierendem enzymprodukt aus streptomyceten zur haltbarmachung von frischfleisch
DE69220259D1 (de) Verfahren zur Herstellung von menschlichem NGF-2
DE69331216D1 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
ATE303158T1 (de) Verwendung von beta-interferon zur behandlung der restenose
DE69617994D1 (de) Verwendung von sulfonamiden zur kontrolle von biobewuchs
ES2058274T3 (es) Un metodo para expresar un producto genico heterologo no bacteriano.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition